Print

Omrix Biopharmaceuticals, Inc. (OMRI) Announces Third Quarter 2008 Financial Results  
11/6/2008 11:12:28 AM

NEW YORK--(BUSINESS WIRE)--Omrix Biopharmaceuticals, Inc. (“Omrix” or the “Company”) (NASDAQ: OMRI), a fully-integrated biopharmaceutical company that develops and markets biosurgical and immunotherapy products, today announced financial results for the third quarter ended September 30, 2008:
//-->